Verrica Pharmaceuticals, Inc. (VRCA)
4.20
+0.02
(+0.48%)
USD |
NASDAQ |
Oct 09, 10:43
Verrica Pharmaceuticals Profit Margin (Quarterly) : -224.4% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -224.4% |
| March 31, 2026 | -192.8% |
| December 31, 2025 | -158.6% |
| September 30, 2025 | -1.91% |
| June 30, 2025 | 1.61% |
| March 31, 2025 | -283.3% |
| December 31, 2024 | -4.71K% |
| September 30, 2024 | |
| June 30, 2024 | -332.0% |
| March 31, 2024 | -531.4% |
| December 31, 2023 | -1.24K% |
| Date | Value |
|---|---|
| September 30, 2023 | -850.3% |
| June 30, 2023 | -6.04K% |
| March 31, 2023 | -17.81K% |
| December 31, 2022 | -8.72K% |
| September 30, 2022 | 1.00% |
| June 30, 2022 | -4.75K% |
| March 31, 2022 | -1.97K% |
| December 31, 2021 | |
| September 30, 2021 | |
| June 30, 2021 | |
| March 31, 2021 | -7.80% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals, Inc. | 8.65% |
| Corcept Therapeutics, Inc. | 16.45% |
| Veru, Inc. | -- |
| Johnson & Johnson | 21.86% |
| Eli Lilly & Co. | 30.88% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -1.47K% |
| Return on Assets | -77.06% |
| Return on Invested Capital | -173.1% |
| Gross Profit Margin (Quarterly) | 85.02% |
| Operating Margin (Quarterly) | -194.5% |
| Return on Net Operating Assets | -222.3% |